对于持续性心房动,导管切除前对电动心脏转变反应的影响:倾向性得分匹配分析
Márton Boga1, Zoltán Salló1, Gábor Orbán1
1Heart and Vascular Center, Semmelweis University, Városmajor Street 68, Budapest 1122, Hungary.
European heart journal open
|July 17, 2025
概括
在持续性心房动 (AF) 患者中,在电动心转动后保持鼻节律,预测了导管切除后的更好的结果. 维持鼻节律 (SR) 的患者在消化后表现出较高的心房动脉节律自由度.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
背景情况:
- 持续性心房动 (AF) 在心血管医学中构成了重大挑战.
- 抗失律药物 (AAD) 和电心转动 (ECV) 是恢复鼻节律 (SR) 的常见策略.
- 在AF患者的导管切除后预测结果对于治疗规划至关重要.
研究的目的:
- 为了研究在术前电心转动 (ECV) 后维持鼻节律 (SR) 是否预测了经过导管切除的持续性心房 (AF) 患者的结果.
- 为了比较导管切除在持续SR后ECV患者和在切除前AF复发的患者中导管切除的疗效.
主要方法:
- 分析了219名在AAD接受ECV治疗的持续性AF患者队列,在去除前1-6个月接受了ECV治疗.
- 患者被分为ECV-SR (维持的SR) 和ECV-AF (AF复发) 基于前剥离节奏.
- 倾向性得分匹配创建了可比较的组 (每组94名患者) 用于结果分析.
- 随访时间中位数为42个月,评估心房动脉节律不变和AF复发.
主要成果:
- 在36个月内,心房动脉节律不变的情况在ECV-SR组 (51.2%) 与ECV-AF组 (31.4%) 相比显著更高.
- 复发模式不同,在ECV-AF组中持续性AF更为常见,在ECV-SR组中 Paroxysmal AF更为常见.
- 在ECV-SR组 (84.3%) 与ECV-AF组 (54%) 相比,在36个月内不受持续性AF的影响也明显好.
- 这些发现在多变量调整和子组中保持一致,包括仅用于肺静脉隔离 (PVI) 的手术.
结论:
- 在术前ECV后维持SR是持续性AF患者导管切除成功结果的强有力的预测指标.
- 对ECV的阳性反应可能会确定适合肺静脉隔离 (PVI) 单纯消去策略的患者.
- 这些结果突出显示了在指导AF管理时,可预测的前剥离前节律状态的预后价值.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
168
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168
Cardiopulmonary Resuscitation III: AED Use
72
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
72
Cardiopulmonary Resuscitation IV: Pharmacological Management
80
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
80
Dysrhythmias VI: Management of Dysrhythmias
110
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
110
Disturbances in Heart Rhythm
1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
Cardiac Catheterization I: Pre-Procedure Overview
167
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
167


